Progen Industries (ASX:PGL) is trading on ASX at a large discount to the price on the US market.
In the past few weeks the volume traded in USA has increased and last night more than 1 mil. shares traded (big vol. for this stock) on NASDAQ where PGLAF closed @ US$0.83 = A$1.27. One PGLAF = one PGL.
Can't explain why PGL is trading at such a discount in OZ.
Today (11 June) Progen will be having presentations for shareholders in Brisbane and Sydney. 12 June in Melbourne.
Prof. John Zalcberg, a non-executive director, will give a presentation on PI-88 clinical development program with clinical interpretation.
My guess is that biotech investors in US are aware of the content of this presentation.
Progen Industries (ASX:PGL) is trading on ASX at a large...
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.46M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 402845 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 97049 | 5 |
View Market Depth
| Last trade - 10.06am 04/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |
Day chart unavailable